Sanofi
SNY
624 hedge funds and large institutions have $12.2B invested in Sanofi in 2021 Q4 according to their latest regulatory filings, with 102 funds opening new positions, 221 increasing their positions, 194 reducing their positions, and 45 closing their positions.
343% more call options, than puts
Call options by funds: $185M | Put options by funds: $41.7M
127% more first-time investments, than exits
New positions opened: 102 | Existing positions closed: 45
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
14% more repeat investments, than reductions
Existing positions increased: 221 | Existing positions reduced: 194
8% more funds holding
Funds holding: 577 → 624 (+47)
7% more capital invested
Capital invested by funds: $11.4B → $12.2B (+$819M)
0.63% more ownership
Funds ownership: 18.72% → 19.34% (+0.63%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$116M |
| 2 |
Morgan Stanley
New York
|
+$66M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$53M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$39.6M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$44.7M |
| 2 |
Dodge & Cox
San Francisco,
California
|
-$35.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$34.3M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$27.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$17.8M |
SNY Hedge Fund Activity: Q4 2021 in Review
624 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2021, worth a combined $12.2B — up 7.2% from $11.4B a quarter earlier.
Buyers outnumbered sellers: 102 funds opened new SNY positions and 45 closed out — a net gain of 57 holders — while 221 added to existing stakes and 194 trimmed.
The largest buyer was Boston Partners, adding an estimated $116M. The largest seller was BlackRock, cutting an estimated $44.7M.
- 624 institutional investors held Sanofi (SNY) as of Q4 2021, up from 577 in Q3 2021.
- Funds reported $12.2B of Sanofi stock for Q4 2021, up 7.2% quarter-over-quarter.
- 102 funds opened new Sanofi positions in Q4 2021 and 45 closed out, a net change of +57 holders.
- The largest Sanofi buyer in Q4 2021 was Boston Partners, an estimated $116M added.
- The largest Sanofi seller in Q4 2021 was BlackRock, an estimated $44.7M sold.
Based on aggregated 13F filings for Q4 2021.